American Type Culture Collection, Manassas, VA

American Type Culture Collection

www.atcc.org

ATCC, the premier global biological materials resource and standards organization serves and supports the scientific community with industry-standard products and innovative solutions. With the world’s largest and most diverse collection of human and animal cell lines, microorganisms, nucleic acids, molecular genomic tools, and biological products, ATCC is a trusted resource for the worldwide research community. Together, the people of ATCC share in its mission to acquire, authenticate, preserve, develop, and distribute biological materials and information for the advancement of scientific knowledge.

Number of Employees: 250-1000
Annual Revenue: $10-50 Million

www.atcc.org
10801 University Blvd
Manassas, VA USA 20110
Phone: 703.365.2700

Executives

Name	Title	Contact Details
Leka Papazisi	Director, Microbiology R&D	Profile
Michael Amiri	Director of Talent Acquisition	Profile
Teri Sellars	Vice President, Human Resources/Chief People Officer	Profile
Teri Sellars	Vice President of Human Resources and Chief People Officer	Profile

Similar Companies

Divergence

Divergence is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

miR Scientific

miR’s Disease Management Platform™ gives providers and patients first-time access to actionable health data, illuminating a clear path to cancer management.

Gene Logic

Gene Logic is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Med-Metrix

Med-Metrix is a leading provider of performance management analytics, consulting, extended business office, and revenue recovery services to the healthcare industry. Our firm was founded by a veteran management team with a successful track record providing superior service and technology to Hospitals.

Clementia Pharmaceuticals

Clementia is a biopharmaceutical company that is focused on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease. Our lead program is palovarotene for Fibrodysplasia Ossificans Progressiva (FOP).